# US 2026/0083694 A1 · Composition comprising l-leucine and fish oil

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083694 A1
- Document ID: US20260083694A1
- Status: Published application
- Kind: A1
- Application number: 19/109,400
- Filed: 2023-09-05
- Published: 2026-03-26
- Earliest claimed: 2022-09-14
- Assignees: Abiogen Pharma S.P.A.
- Applicants: Abiogen Pharma S.P.A.
- Inventors: Mattia Sfriso; Mauro Bonini; Sara Feltrin; Lucia Florian
- Web page: https://patentgrep.com/patent/US20260083694A1

## CPC

- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A23L 29/10: containing emulsifiers
- A23L 29/25: Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
- A23L 29/27: {Xanthan not combined with other microbial gums}
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A23L 33/175: Amino acids
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 35/60: Fish, e.g. seahorses; Fish eggs
- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 2035/115: {Probiotics}
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention concerns a composition comprising L-leucine and fish oil usable to supplement leucine and omega 3 in subjects in need thereof. The invention also concerns the use of the said composition in the treatment of muscle 5 tissue pathologies, in particular for the prevention of muscle pathologies characterised by loss of muscle mass and/or muscle strength, such as sarcopenia.

## Claims

### Claim 1

Composition comprising L-leucine, fish oil, polyoxyethylene sorbitan monooleate, and at least one gum, wherein the weight ratio of gum to fish oil is higher than 0.3 and lower than 0.8, and wherein the weight ratio of polyoxyethylene sorbitan monooleate to L-leucine is higher than 0.01 and lower than 0.06.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said at least one gum is selected from Gum arabic, xanthan gum, mesquite gum, and their mixtures.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the weight ratio of gum to fish oil is 0.4 to 0.7.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the weight ratio of polyoxyethylene sorbitan monooleate to L-leucine is 0.02 to 0.05, preferably 0.02 to 0.03.

### Claim 5 (depends on 1)

The composition of claim 1, further comprising a fat-soluble aroma and, optionally, a water-soluble aroma.

### Claim 6 (depends on 1)

The composition of claim 1, further comprising a coating agent.

### Claim 7 (depends on 1)

Dietary supplement or food comprising the composition of claim 1 and suitable food carriers.

### Claim 8 (depends on 7)

The dietary supplement or food of claim 7, further comprising at least one probiotic.

### Claim 9 (depends on 1)

The composition of claim 1 or a dietary supplement or food comprising the composition of claim 1 and suitable food carrier, in solid form selected from tablet, mini-tablet, micro-tablet, granule, micro-granule, pellet, multi-particulate, micronized particulate, and powder.

### Claim 10 (depends on 9)

The composition, dietary supplement or food of claim 9, in the form of a unit dose comprising 2-10 g of a composition comprising
L-leucine,
fish oil,
polyoxyethylene sorbitan monooleate, and at least one gum,
wherein the weight ratio of gum to fish oil is higher than 0.3 and lower than 0.8, and wherein the weight ratio of polyoxyethylene sorbitan monooleate to L-leucine is higher than 0.01 and lower than 0.06.

### Claim 11 (depends on 1)

A method of treating muscle pathologies in a patient in need thereof, the method comprising
administering to said patient a therapeutically effective amount of the composition of claim 1 or a dietary supplement or food comprising the composition of claim 1 and suitable food carriers.

### Claim 12 (depends on 11)

The method of claim 11, wherein the muscle tissue pathology is sarcopenia.

### Claim 13 (depends on 11)

The method of claim 11, wherein a composition comprising
L-leucine,
fish oil,
polyoxyethylene sorbitan monooleate, and at least one gum,
optionally with suitable food carriers;
wherein the weight ratio of gum to fish oil is higher than 0.3 and lower than 0.8, and wherein the weight ratio of polyoxyethylene sorbitan monooleate to L-leucine is higher than 0.01 and lower than 0.06 is to be administered via oral, buccal or sublingual route.

### Claim 14 (depends on 11)

The method of claim 11, wherein a composition comprising
L-leucine,
fish oil,
polyoxyethylene sorbitan monooleate, and at least one gum,
optionally with suitable food carriers;
wherein the weight ratio of gum to fish oil is higher than 0.3 and lower than 0.8, and wherein the weight ratio of polyoxyethylene sorbitan monooleate to L-leucine is higher than 0.01 and lower than 0.06, is to be administered at a daily dose so as to provide 1-5 g of L-leucine and up to 1 g of fish oil.

### Claim 15 (depends on 2)

The composition of claim 2, wherein said at least one gum is Arabic gum or a mixture of Arabic gum and xanthan gum.

### Claim 16 (depends on 3)

The composition of claim 3, wherein the weight ratio of gum to fish oil is 0.5 to 0.6.

### Claim 17 (depends on 4)

The composition of claim 4, wherein the weight ratio of polyoxyethylene sorbitan monooleate to L-leucine is 0.02 to 0.03.

### Claim 18 (depends on 6)

The composition of claim 6, wherein the coating agent comprises ethylcellulose, hydroxypropylcellulose, hydroxypropylmethyl cellulose, cellulose, fatty acids, medium chain triglycerides or a mixture thereof.

### Claim 19 (depends on 9)

The composition or the dietary food of claim 9, in the form of a unit dose comprising 4-6 g of a composition comprising
L-leucine,
fish oil,
polyoxyethylene sorbitan monooleate, and at least one gum,
wherein the weight ratio of gum to fish oil is higher than 0.3 and lower than 0.8, and wherein the weight ratio of polyoxyethylene sorbitan monooleate to L-leucine is higher than 0.01 and lower than 0.06.
